Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
005950.KS Stock Summary
Top 10 Correlated ETFs
005950.KS
In the News
005950.KS Financial details
Company Rating
Neutral
Market Cap
306.45B
Income
-47.43B
Revenue
1995.49B
Book val./share
7143.85
Cash/share
11291.26
Dividend
500
Dividend %
3.7%
Employees
301
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-12.43
Forward P/E
-
PEG
0.14
P/S
0.13
P/B
1.64
P/C
1.17
P/FCF
-2.38
Quick Ratio
-
Current Ratio
1.02
Debt / Equity
3.08
LT Debt / Equity
0.48
-
-
EPS (TTM)
-2.15K
EPS next Y
-
EPS next Q
-
EPS this Y
-599.09%
EPS next Y
-
EPS next 5Y
-197.26%
EPS last 5Y
-3.65%
Revenue last 5Y
5.65%
Revenue Q/Q
-26.1%
EPS Q/Q
572.55%
-
-
-
-
SMA20
2.63%
SMA50
3%
SMA100
10.52%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-12%
ROC
-0.11%
Gross Margin
3%
Oper. Margin
-2%
Profit Margin
-1%
Payout
-
Shs Outstand
22.08M
Shs Float
15.32M
-
-
-
-
Target Price
-
52W Range
11730.0-38850.0
52W High
-65.97%
52W Low
+12.7%
RSI
44
Rel Volume
0.42
Avg Volume
708.05K
Volume
300.25K
Perf Week
-6.57%
Perf Month
1.15%
Perf Quarter
-14.16%
Perf Half Y
-12.97%
-
-
-
-
Beta
1.09
-
-
Volatility
279.48%, 523.95%
Prev Close
-3.57%
Price
13220
Change
-2.15%
005950.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 117.3K | 91.85K | 80.85K | 20.54K | 84.18K | |
Net income per share | -1.59K | -10.01K | 4.46K | 257.96 | -1.32K | |
Operating cash flow per share | -420.65 | 5.77K | 2.9K | -309.5 | -3.53K | |
Free cash flow per share | -4.25K | 4.45K | 2.44K | -780.5 | -5.33K | |
Cash per share | 6.37K | 13.77K | 12.74K | 1.46K | 10.52K | |
Book value per share | 23.5K | 17.5K | 13.47K | 2.84K | 6.65K | |
Tangible book value per share | 27.77K | 18.33K | 17.63K | 3.53K | 11K | |
Share holders equity per share | 23.5K | 17.5K | 13.47K | 2.84K | 6.65K | |
Interest debt per share | 36.51K | 34.95K | 23.42K | 4.44K | 21.94K | |
Market cap | 61.89B | 94.48B | 153.45B | 971.24B | 325.92B | |
Enterprise value | 456.07B | 382.29B | 387.66B | 1305.94B | 627.68B | |
P/E ratio | -3.01 | -0.66 | 1.63 | 35.03 | -10.42 | |
Price to sales ratio | 0.04 | 0.07 | 0.09 | 0.44 | 0.16 | |
POCF ratio | -11.38 | 1.15 | 2.52 | -29.2 | -3.89 | |
PFCF ratio | -1.13 | 1.49 | 2.99 | -11.58 | -2.58 | |
P/B Ratio | 0.2 | 0.38 | 0.54 | 3.18 | 2.07 | |
PTB ratio | 0.2 | 0.38 | 0.54 | 3.18 | 2.07 | |
EV to sales | 0.3 | 0.29 | 0.23 | 0.59 | 0.31 | |
Enterprise value over EBITDA | 13.2 | -10.05 | 2.65 | 17.47 | -16.85 | |
EV to operating cash flow | -83.88 | 4.64 | 6.35 | -39.26 | -7.5 | |
EV to free cash flow | -8.3 | 6.01 | 7.55 | -15.57 | -4.97 | |
Earnings yield | -0.33 | -1.52 | 0.61 | 0.03 | -0.1 | |
Free cash flow yield | -0.89 | 0.67 | 0.33 | -0.09 | -0.39 | |
Debt to equity | 1.49 | 1.9 | 1.67 | 1.49 | 3.08 | |
Debt to assets | 0.42 | 0.49 | 0.41 | 0.38 | 0.44 | |
Net debt to EBITDA | 11.41 | -7.56 | 1.6 | 4.48 | -8.1 | |
Current ratio | 1.18 | 1.01 | 1.28 | 1 | 1.12 | |
Interest coverage | 0.92 | -1.39 | 6.57 | 2.18 | -1.68 | |
Income quality | 0.29 | -0.58 | 0.63 | -1.27 | 1.96 | |
Dividend Yield | 0.15 | 0.1 | 0.05 | 0.02 | 0.05 | |
Payout ratio | -0.45 | -0.06 | 0.08 | 0.72 | -0.47 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Capex to operating cash flow | 9.11 | -0.23 | -0.16 | 1.52 | 0.51 | |
Capex to revenue | -0.03 | -0.01 | -0.01 | -0.02 | -0.02 | |
Capex to depreciation | -2.83 | -0.87 | -0.41 | -2.08 | -2.1 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 28.98K | 62.79K | 36.78K | 4.06K | 14.05K | |
ROIC | 0.09 | -0.04 | 0.13 | 0.05 | -0.09 | |
Return on tangible assets | -0.02 | -0.15 | 0.08 | 0.02 | -0.03 | |
Graham Net | -21.36K | -19.17K | -11.57K | -2.94K | -12.68K | |
Working capital | 84.67B | 4.62B | 146.74B | 1.76B | 76.8B | |
Tangible asset value | 358.92B | 262.15B | 371.41B | 379.2B | 260.66B | |
Net current asset value | -125.03B | -170.39B | -108.56B | -134.59B | -136.55B | |
Invested capital | 1.49 | 1.9 | 1.67 | 1.49 | 3.08 | |
Average receivables | 311.48B | 285.47B | 234.41B | 254.88B | 276.9B | |
Average payables | 49.5B | 68.03B | 81.07B | 109.49B | 127.32B | |
Average inventory | 121.72B | 112.49B | 125.72B | 192.51B | 177.44B | |
Days sales outstanding | 85.36 | 60.12 | 54.11 | 42.53 | 54.24 | |
Days payables outstanding | 16.07 | 22.66 | 21.29 | 23.14 | 23.3 | |
Days of inventory on hand | 32.09 | 30.85 | 36.37 | 41.47 | 22.72 | |
Receivables turnover | 4.28 | 6.07 | 6.75 | 8.58 | 6.73 | |
Payables turnover | 22.72 | 16.11 | 17.14 | 15.78 | 15.66 | |
Inventory turnover | 11.37 | 11.83 | 10.04 | 8.8 | 16.07 | |
ROE | -0.07 | -0.57 | 0.33 | 0.09 | -0.2 | |
Capex per share | -3.83K | -1.32K | -458.81 | -471 | -1.8K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 24.43K | 24.93K | 24.37K | 23.44K | 17.27K | |
Net income per share | -455.07 | -993.49 | 558.12 | -225.29 | -1.52K | |
Operating cash flow per share | 825.23 | -2.31K | -445.23 | -1.87K | 1.03K | |
Free cash flow per share | 403.96 | -2.71K | -1.13K | -2.17K | 503.92 | |
Cash per share | 5.77K | 7.48K | 8.34K | 10.96K | 11.29K | |
Book value per share | 11.23K | 8.42K | 9.04K | 9.07K | 7.14K | |
Tangible book value per share | 13.93K | 11.63K | 12.08K | 11.93K | 11.81K | |
Share holders equity per share | 11.23K | 8.42K | 9.04K | 9.07K | 7.14K | |
Interest debt per share | 16.94K | 20.28K | 21.72K | 23.24K | 22.8K | |
Market cap | 245.9B | 522.2B | 596.47B | 338.88B | 303.58B | |
Enterprise value | 580.6B | 850.37B | 973.28B | 665.54B | 605.34B | |
P/E ratio | -4.96 | -6.02 | 11.76 | -17.09 | -2.27 | |
Price to sales ratio | 0.37 | 0.96 | 1.08 | 0.66 | 0.8 | |
POCF ratio | 10.95 | -10.36 | -58.96 | -8.22 | 13.35 | |
PFCF ratio | 22.37 | -8.81 | -23.3 | -7.09 | 27.29 | |
P/B Ratio | 0.8 | 2.84 | 2.9 | 1.7 | 1.92 | |
PTB ratio | 0.8 | 2.84 | 2.9 | 1.7 | 1.92 | |
EV to sales | 0.87 | 1.56 | 1.76 | 1.29 | 1.59 | |
Enterprise value over EBITDA | -24.95 | 79.44 | 45.25 | 47.04 | -37.08 | |
EV to operating cash flow | 25.85 | -16.87 | -96.2 | -16.15 | 26.62 | |
EV to free cash flow | 52.81 | -14.35 | -38.02 | -13.91 | 54.41 | |
Earnings yield | -0.05 | -0.04 | 0.02 | -0.01 | -0.11 | |
Free cash flow yield | 0.04 | -0.11 | -0.04 | -0.14 | 0.04 | |
Debt to equity | 1.49 | 2.47 | 2.35 | 2.52 | 3.08 | |
Debt to assets | 0.38 | 0.36 | 0.45 | 0.46 | 0.44 | |
Net debt to EBITDA | -14.38 | 30.66 | 17.52 | 23.09 | -18.48 | |
Current ratio | 1 | 0.94 | 0.98 | 1.02 | 1.12 | |
Interest coverage | -1.32 | 1.37 | -0.76 | -1.52 | -1.16 | |
Income quality | -1.81 | 6.37 | -0.81 | 8.23 | -0.68 | |
Dividend Yield | 0 | 0 | 0.02 | 0 | 0 | |
Payout ratio | 0 | 0 | 1.07 | 0 | -0.03 | |
Sales general and administrative to revenue | 0 | 0.05 | 0.05 | 0.05 | 0 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.03 | 0 | |
Capex to operating cash flow | -0.51 | 0.18 | 1.53 | 0.16 | -0.51 | |
Capex to revenue | -0.02 | -0.02 | -0.03 | -0.01 | -0.03 | |
Capex to depreciation | -1.82 | -1.39 | -2.85 | -1.34 | -2.82 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.72K | 13.72K | 10.66K | 6.78K | 15.61K | |
ROIC | -0.01 | -0.03 | -0.01 | -0.05 | -0.03 | |
Return on tangible assets | -0.01 | -0.02 | 0.01 | 0 | -0.03 | |
Graham Net | -11.6K | -17.92K | -12.72K | -12.52K | -13.61K | |
Working capital | 1.76B | -55.83B | -14.94B | 13.85B | 76.8B | |
Tangible asset value | 379.2B | 254.03B | 274.38B | 262.59B | 260.66B | |
Net current asset value | -134.59B | -168.41B | -112.08B | -99.25B | -136.55B | |
Invested capital | 1.49 | 2.47 | 2.35 | 2.52 | 3.08 | |
Average receivables | 275.84B | 352.72B | 368.82B | 282.22B | 285.76B | |
Average payables | 114.36B | 108.82B | 87.82B | 95.73B | 113.66B | |
Average inventory | 221.54B | 198.26B | 156.37B | 150.58B | 136.16B | |
Days sales outstanding | 34.83 | 74.05 | 47.05 | 47.97 | 70.01 | |
Days payables outstanding | 18.43 | 14.7 | 14.95 | 18.49 | 30.07 | |
Days of inventory on hand | 33.04 | 27.43 | 25.36 | 27.12 | 29.31 | |
Receivables turnover | 2.58 | 1.22 | 1.91 | 1.88 | 1.29 | |
Payables turnover | 4.88 | 6.12 | 6.02 | 4.87 | 2.99 | |
Inventory turnover | 2.72 | 3.28 | 3.55 | 3.32 | 3.07 | |
ROE | -0.04 | -0.12 | 0.06 | -0.02 | -0.21 | |
Capex per share | -421.27 | -405.5 | -681.4 | -300.91 | -526.07 |
005950.KS Frequently Asked Questions
What is ISU Chemical Co., Ltd stock symbol ?
ISU Chemical Co., Ltd is a KR stock and trading under the symbol 005950.KS
What is ISU Chemical Co., Ltd stock quote today ?
ISU Chemical Co., Ltd stock price is $13220 today.
Is ISU Chemical Co., Ltd stock public?
Yes, ISU Chemical Co., Ltd is a publicly traded company.